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The point of departure is the conceptof socio-genetic marginalization in
Asia. It draws attention to the conse-
quences of the practice of relating the
social to the (assumed) genetic make-up
of people, even when the relevance of
such a connection is doubtful. After all,
it is from the cultural (including the spir-
itual), socio-economic, and political con-
text that we derive the sources that
endow our interpretations of genetic
information with meaning. The concept
of socio-genetic marginalization, first of
all, refers to the isolation of social groups
and individuals as a consequence of dis-
crimination on the basis of genetic infor-
mation. With this in mind, my paper dis-
cusses the vulnerable position of ethnic
groups in China, India, and Taiwan,
when facing decisions about revealing
their genetic identity by contributing
genetic samples to researchers, often
under pressure or in exchange for prom-
ises of health care. Socio-genetic mar-
ginalization also refers to the ‘special’
position of socio-genetic risk groups that
have to deal with the psychological bur-
den of the knowledge, feelings of social
ineptitude, and a sense of financial
uncertainty. Drawing on a large multi-
sited ethnographic research project,
exploring infertility and medically-assist-
ed conception in India’s five major cities,
Aditya Bharadwai (Cardiff University,
Wales) examines how a biological inabil-
ity to reproduce not only disrupts repro-
genetic futures of the infertile but also
results in bio-social marginalization.
Finally, the socio-genetic marginaliza-
tion also indicates forms of socio-eco-
nomic marginalization when, for
instance, health care becomes too costly
for the socio-economically disadvan-
taged.
The development of priorities and
practices of screening and testing for
congenital diseases in different soci-
eties varies. A central question is, what
are the health care needs and interests
of different population groups with
regards to genetic testing, and how are
they reflected in health care policies?
The health care strategies, priorities,
and socio-psychological (de-)merits,
and the economic rationale of preven-
tive screening, will be central issues of
debate. In this context, Jyotsna Gupta
(Leiden University Medical Centre, the
Netherlands) questions the practice in
India of diverting vast sums of public
sector health funds to studying the bur-
den of genetic disease. A major part of
perinatal morbidity and mortality, as
well as infant mortality, may be ascribed
to undernourishment and malnutrition
of both mother and child, and a lack of
antenatal and postnatal services. Her
paper offers ideas for alternative health
care strategies that lie in the sphere of
public policy-making and education.
The public debate on genomics must
go beyond the mere dissemination of
knowledge. Some suggestions on how
to organize the debate seem to be
unworkable in the short-term. Thus, we
cannot expect to realize the ideals of
public empowerment, client compe-
tency, and democratic decision-making
concerning the development and appli-
cation of new genetic technologies in
time to be effective, especially not on a
global scale. To illustrate this point,
Jing-Bao Nie (University of Otago, New
Zealand) discusses the Chinese eugen-
ics project, which relies on ideologies
such as social Darwinism, biological
determinism, statism, and scientism
for its execution, and is reductionist in
addressing complex social problems.
Nie considers the possible damaging
effects of these ideologies, such as the
further marginalization of the vulnera-
ble, genetic victimization of the inno-
cent, and the encouragement of author-
itarian state policies and technocracy. 
To start with, a more feasible target
would be to aim at a better under-
standing of the consideration of issues
amongst different interest groups. In
this spirit, Tsai Duujian (National Yang
Ming University, Taiwan) explores the
interactions between these groups, as
well as the interaction between such
groups and the Taiwanese Govern-
ment. He proposes a concept of partic-
ipatory democracy that may avoid
potential conflicts between technolog-
ical development and humanistic inter-
est, and could coordinate industry,
medical societies, and patient groups
in working collectively to shape genom-
ic policy. Kaori Muto’s paper (Shinshu
University, Japan) explores the concept
of genetic citizenship in her study of
Japanese families with Huntington’s
Disease. The notion of genetic citizen-
ship will gain importance, as genomics
will be increasingly socialized through
developments in molecular epidemiol-
ogy. This will require new strategies of
public health care. <
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The increased public and political concern about developments of new genetic technologies
has led to an increased scrutiny of the role played by medical experts and public health
authorities in their introduction into the health care system. Public discussion,
recommendations of professional organizations, legislation, and reliable technological
assessment are relied upon to prevent any adverse effects on society. It is also important to
organize discussions on an international level. The aim of this ICAS3 panel, confined to
developments in China, Japan, India, and Taiwan, is to make a contribution to that effect.
